A study to assess how effective and safe is the moisturizer for patients having acne who areprescribed isotretinoi
Phase 4
Completed
- Conditions
- Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue
- Registration Number
- CTRI/2019/07/020458
- Lead Sponsor
- Cipla Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
1. A voluntarily given, written signed dated data sharing consent from participants and/or legally acceptable representative.
2. Participants of 18 years and above of either gender who are newly prescribed Isotretinoin or who have not used oral isotretinoin for past one month for the management of acne and moisturiser (Excela) as an adjuvant therapy as per Investigatorââ?¬•s discretion.
Exclusion Criteria
1.Any skin allergy or serious skin condition or unsuitable to participate in the study as per routine clinical practice.
2.Pregnant and lactating women
3.Participated in any clinical trial within 1 month from screening
Study & Design
- Study Type
- PMS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method